Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALIM

Alimera Sciences (ALIM) Stock Price, News & Analysis

Alimera Sciences logo

About Alimera Sciences Stock (NASDAQ:ALIM)

Advanced Chart

Key Stats

Today's Range
$5.54
$5.54
50-Day Range
$5.19
$5.60
52-Week Range
$2.61
$5.65
Volume
N/A
Average Volume
376,318 shs
Market Capitalization
$290.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alimera Sciences and its competitors with MarketBeat's FREE daily newsletter.

ALIM Stock News Headlines

Alimera Sciences Inc.
ANI Pharmaceuticals’ Record Growth and Strategic Acquisition
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Alimera Sciences, Inc. (NASDAQ:ALIM): When Will It Breakeven?
Alimera Sciences, Inc. (ALIM)
See More Headlines

ALIM Stock Analysis - Frequently Asked Questions

Alimera Sciences, Inc. (NASDAQ:ALIM) posted its earnings results on Tuesday, August, 6th. The biopharmaceutical company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The biopharmaceutical company earned $27 million during the quarter, compared to the consensus estimate of $25.76 million. Alimera Sciences had a negative net margin of 14.74% and a negative trailing twelve-month return on equity of 33.70%.

Alimera Sciences shares reverse split on the morning of Friday, November 15th 2019.The 1-15 reverse split was announced on Thursday, November 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 14th 2019. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alimera Sciences investors own include Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
8/06/2024
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALIM
CIK
1267602
Employees
150
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
($1.57)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.13 million
Net Margins
-14.74%
Pretax Margin
-14.76%
Return on Equity
-33.70%
Return on Assets
-9.63%

Debt

Debt-to-Equity Ratio
1.80
Current Ratio
2.79
Quick Ratio
2.62

Sales & Book Value

Annual Sales
$99.68 million
Price / Sales
2.91
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.88 per share
Price / Book
6.30

Miscellaneous

Outstanding Shares
52,389,000
Free Float
35,939,000
Market Cap
$290.24 million
Optionable
Optionable
Beta
1.25

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ALIM) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners